Dapagliflozin for Chronic Kidney Disease | Zendy

AI Assistant Blog Pricing

Open Access

Dapagliflozin for Chronic Kidney Disease

Author(s) -

Sara D. Khangura,

Melissa Severn

Publication year - 2022

Publication title -

canadian journal of health technologies

Language(s) - Uncategorized

Resource type - Journals

ISSN - 2563-6596

DOI - 10.51731/cjht.2022.354

Subject(s) - dapagliflozin , medicine , kidney disease , placebo , renal function , intensive care medicine , adverse effect , diabetes mellitus , randomized controlled trial , clinical trial , disease , type 2 diabetes , alternative medicine , endocrinology , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.